RNF43 G659fs is an oncogenic colorectal cancer mutation and sensitizes tumor cells to PI3K/mTOR inhibition
暂无分享,去创建一个
Steven M. Corsello | Steve Carr | K. Ng | Srivatsan Raghavan | M. Giannakis | Lishan Fang | E. Sicinska | X. Xiong | C. O'Brien | Dane Ford-Roshon | Max Russo | Carino Gurjao | M. Grandclaudon | N. Udeshi | Jim Berstler | Max Russo | S. M. Corsello | Maximilien Grandclaudon
[1] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[2] R. Smits,et al. The Functional Landscape of Patient-Derived RNF43 Mutations Predicts Sensitivity to Wnt Inhibition , 2020, Cancer Research.
[3] R. Lindeboom,et al. RNF43 truncations trap CK1 to drive niche‐independent self‐renewal in cancer , 2020, The EMBO journal.
[4] Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.
[5] R. Jamal,et al. Actionable Potentials of Less Frequently Mutated Genes in Colorectal Cancer and Their Roles in Precision Medicine , 2020, Biomolecules.
[6] R. Smits,et al. Commonly observed RNF43 mutations retain functionality in attenuating Wnt/β-catenin signaling and unlikely confer Wnt-dependency onto colorectal cancers , 2020, Oncogene.
[7] Angela N. Brooks,et al. eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants , 2019, bioRxiv.
[8] G. Lesinski,et al. Immune checkpoint inhibitors for the treatment of MSI-H/MMR-D colorectal cancer and a perspective on resistance mechanisms , 2019, British Journal of Cancer.
[9] Soohyung Park,et al. The most common RNF43 mutant G659Vfs*41 is fully functional in inhibiting Wnt signaling and unlikely to play a role in tumorigenesis , 2019, Scientific Reports.
[10] Jun Yu,et al. Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity , 2019, Nature Microbiology.
[11] Haifeng Liu,et al. FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells , 2018, Nature.
[12] Wei Yang,et al. FBXO38 mediates PD-1 ubiquitination and regulates anti-tumour immunity of T cells , 2018, Nature.
[13] W. Cheung,et al. Metastatic Colorectal Cancer in the Era of Personalized Medicine: A More Tailored Approach to Systemic Therapy , 2018, Canadian journal of gastroenterology & hepatology.
[14] Bon-Kyoung Koo,et al. Divergent Routes toward Wnt and R-spondin Niche Independency during Human Gastric Carcinogenesis , 2018, Cell.
[15] Ritika Kundra,et al. Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer. , 2018, Cancer cell.
[16] Kentaro Inamura,et al. Colorectal Cancers: An Update on Their Molecular Pathology , 2018, Cancers.
[17] Jing Wang,et al. The Advantages of Targeted Protein Degradation Over Inhibition: An RTK Case Study. , 2017, Cell chemical biology.
[18] Philip S Rosenberg,et al. Colorectal Cancer Incidence Patterns in the United States, 1974–2013 , 2017, Journal of the National Cancer Institute.
[19] L. Cantley,et al. PI3K-p110α mediates the oncogenic activity induced by loss of the novel tumor suppressor PI3K-p85α , 2017, Proceedings of the National Academy of Sciences.
[20] Lovelace J. Luquette,et al. A Pan-Cancer Proteogenomic Atlas of PI3K/AKT/mTOR Pathway Alterations. , 2017, Cancer cell.
[21] Jacob K. Asiedu,et al. The Drug Repurposing Hub: a next-generation drug library and information resource , 2017, Nature Medicine.
[22] Yiling Lu,et al. Characterization of Human Cancer Cell Lines by Reverse-phase Protein Arrays. , 2017, Cancer cell.
[23] H. Clevers,et al. RNF43 germline and somatic mutation in serrated neoplasia pathway and its association with BRAF mutation , 2016, Gut.
[24] S. Gabriel,et al. Genomic Correlates of Immune-Cell Infiltrates in Colorectal Carcinoma , 2016, Cell reports.
[25] H. Clevers,et al. Porcupine inhibitor suppresses paracrine Wnt-driven growth of Rnf43;Znrf3-mutant neoplasia , 2015, Proceedings of the National Academy of Sciences.
[26] Hayley E. Francies,et al. Prospective Derivation of a Living Organoid Biobank of Colorectal Cancer Patients , 2015, Cell.
[27] Yang Zhang,et al. I-TASSER server: new development for protein structure and function predictions , 2015, Nucleic Acids Res..
[28] Jean J. Zhao,et al. PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting , 2014, Nature Reviews Cancer.
[29] Kristian Cibulskis,et al. RNF43 is frequently mutated in colorectal and endometrial cancers , 2014, Nature Genetics.
[30] Liam O'Connor,et al. Colorectal cancer cell lines are representative models of the main molecular subtypes of primary cancer. , 2014, Cancer research.
[31] Prahlad T. Ram,et al. A pan-cancer proteomic perspective on The Cancer Genome Atlas , 2014, Nature Communications.
[32] Feng Cong,et al. Inactivating mutations of RNF43 confer Wnt dependency in pancreatic ductal adenocarcinoma , 2013, Proceedings of the National Academy of Sciences.
[33] Jeffrey J Meyer,et al. Cancer Genome Atlas Network. Comprehensive molecular characterization of human colon and rectal cancer. Nature 2012. (5) , 2013 .
[34] Y. Liu,et al. Activation of PI3K/Akt pathway by CD133-p85 interaction promotes tumorigenic capacity of glioma stem cells , 2013, Proceedings of the National Academy of Sciences.
[35] E. Lander,et al. Lessons from the Cancer Genome , 2013, Cell.
[36] H. Clevers,et al. Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptors , 2012, Nature.
[37] Steven J. M. Jones,et al. Comprehensive molecular characterization of human colon and rectal cancer , 2012, Nature.
[38] H. Ruffner,et al. ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive manner , 2012, Nature.
[39] G. Mills,et al. High frequency of PIK3R1 and PIK3R2 mutations in endometrial cancer elucidates a novel mechanism for regulation of PTEN protein stability. , 2011, Cancer discovery.
[40] Yang Zhang,et al. I-TASSER: a unified platform for automated protein structure and function prediction , 2010, Nature Protocols.
[41] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[42] L. Cantley,et al. Then Negative Regulation of Phosphoinositide 3-Kinase Signaling by p85 and Its Implication in Cancer , 2005 .
[43] L. Cantley,et al. The negative regulation of phosphoinositide 3-kinase signaling by p85 and it's implication in cancer. , 2005, Cell cycle.
[44] C. Sawyers,et al. The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.